RU99113429A - GUANIDINYLAMINOHETEROCYCLIC COMPOUNDS, AS AN AGONISTS OF ALPHA-2 ADRENOCEPTORS - Google Patents
GUANIDINYLAMINOHETEROCYCLIC COMPOUNDS, AS AN AGONISTS OF ALPHA-2 ADRENOCEPTORSInfo
- Publication number
- RU99113429A RU99113429A RU99113429/04A RU99113429A RU99113429A RU 99113429 A RU99113429 A RU 99113429A RU 99113429/04 A RU99113429/04 A RU 99113429/04A RU 99113429 A RU99113429 A RU 99113429A RU 99113429 A RU99113429 A RU 99113429A
- Authority
- RU
- Russia
- Prior art keywords
- hydrogen
- unsubstituted
- methyl
- amino
- compound according
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims 12
- 102000017910 Adrenergic receptor family Human genes 0.000 title claims 2
- 108060003345 Adrenergic receptor family Proteins 0.000 title claims 2
- 239000000556 agonist Substances 0.000 title claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 20
- 239000001257 hydrogen Substances 0.000 claims 20
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 10
- -1 amino, hydroxy, mercapto Chemical class 0.000 claims 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 7
- 125000004455 (C1-C3) alkylthio group Chemical group 0.000 claims 6
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 6
- 229910052801 chlorine Inorganic materials 0.000 claims 6
- 239000000460 chlorine Substances 0.000 claims 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 6
- 229910052736 halogen Inorganic materials 0.000 claims 6
- 150000002367 halogens Chemical class 0.000 claims 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 5
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 5
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims 4
- 125000006698 (C1-C3) dialkylamino group Chemical group 0.000 claims 4
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 3
- XMSZANIMCDLNKA-UHFFFAOYSA-N methyl hypofluorite Chemical compound COF XMSZANIMCDLNKA-UHFFFAOYSA-N 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims 2
- 210000001035 Gastrointestinal Tract Anatomy 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 210000000138 Mast Cells Anatomy 0.000 claims 1
- YECBIJXISLIIDS-UHFFFAOYSA-N Mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 230000000202 analgesic Effects 0.000 claims 1
- 230000001387 anti-histamine Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agents Drugs 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 230000003078 antioxidant Effects 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 239000003434 antitussive agent Substances 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 230000003182 bronchodilatating Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 230000003419 expectorant Effects 0.000 claims 1
- 239000003172 expectorant agent Substances 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000003199 leukotriene receptor blocking agent Substances 0.000 claims 1
- 230000000051 modifying Effects 0.000 claims 1
- 230000000510 mucolytic Effects 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 230000003287 optical Effects 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Claims (11)
где а) R1 представляет водород; или алкил отсутствует; в случае, если R1 отсутствует, связь (а) представляет двойную связь;
b) D представляет СR2, где R2 выбирают из водорода; незамещенного С1-С3 алканила, амино, гидрокси, меркапто; С1-С3 алкилтио или алкокси; С1-С3 алкиламино или С1-С3 диалкиламино и галогена, или если В представляет СR3, D может представлять N;
с) В представляет NR9, СR3=СR8, СR3=N, СR3, S, О, SО или SО2; где R9 выбирают из водорода; незамещенного С1-С3 алканила, алкенила или алкинила; циклоалканила, циклоалкенила; и где R3 и R8 каждый независимо выбирают из водорода; незамещенного С1-С3 алканила, алкенила или алкинила; циклоалканила, циклоалкенила; незамещенного С1-С3 алкилтио или алкокси; гидрокси; тио; нитро; циано; амино; С1-С3 алкиламино или С1-С3 диалкиламино и галогена;
d) R4, R5 и R6 каждый независимо выбирают из водорода; незамещенного С1-С3 алканила, алкенила или алкинила; циклоалканила; циклоалкенила; незамещенного С1-С3 алкилтио или алкокси; гидрокси; тио; нитро; циано; амино; С1-С3 алкиламино или С1-С3 диалкиламино и галогена; и NН-NН-С(=NR10)NНR11 (гуанидиниламино); где R10 и R11 независимо выбирают из водорода; метила и этила; и где один и только один из R4, R5 и R6 представляет гуанидиниламино;
е) R7 выбирают из водорода; незамещенного С1-С3 алканила, алкенила или алкинила; циклоалканила, циклоалкенила; незамещенного С1-С3 алкилтио или алкокси; гидрокси; тио; нитро; циано; амино; С1-С3 алкиламино или С1-С3 диалкиламино и галогена;
и энантиомеры, оптические изомеры, стереоизомеры, диастереоизомеры, таутомеры, соли присоединения, биогидролизуемые амиды и сложные эфиры.1. The compound of the formula
where a) R 1 represents hydrogen; or alkyl is absent; in case R 1 is absent, the bond (a) represents a double bond;
b) D is CR 2 , where R 2 is selected from hydrogen; unsubstituted With 1 -C 3 alkanyl, amino, hydroxy, mercapto; C 1 -C 3 alkylthio or alkoxy; C 1 -C 3 alkylamino or C 1 -C 3 dialkylamino and halogen, or if B is CR 3 , D may be N;
c) B is NR 9 , CR 3 = CR 8 , CR 3 = N, CR 3 , S, O, SO or SO 2 ; where R 9 is selected from hydrogen; unsubstituted With 1 -C 3 alkanyl, alkenyl or quinil; cycloalkyl, cycloalkenyl; and wherein R 3 and R 8 are each independently selected from hydrogen; unsubstituted With 1 -C 3 alkanyl, alkenyl or quinil; cycloalkyl, cycloalkenyl; unsubstituted C 1 -C 3 alkylthio or alkoxy; hydroxy; thio; nitro; cyano; amino; C 1 -C 3 alkylamino or C 1 -C 3 dialkylamino and halogen;
d) R 4 , R 5 and R 6 are each independently selected from hydrogen; unsubstituted With 1 -C 3 alkanyl, alkenyl or quinil; cycloalkyl; cycloalkenyl; unsubstituted C 1 -C 3 alkylthio or alkoxy; hydroxy; thio; nitro; cyano; amino; C 1 -C 3 alkylamino or C 1 -C 3 dialkylamino and halogen; and NH-NH-C (= NR 10 ) NHH 11 (guanidinylamino); where R 10 and R 11 are independently selected from hydrogen; methyl and ethyl; and where one and only one of R 4 , R 5 and R 6 is guanidino amino;
e) R 7 is selected from hydrogen; unsubstituted With 1 -C 3 alkanyl, alkenyl or quinil; cycloalkyl, cycloalkenyl; unsubstituted C 1 -C 3 alkylthio or alkoxy; hydroxy; thio; nitro; cyano; amino; C 1 -C 3 alkylamino or C 1 -C 3 dialkylamino and halogen;
and enantiomers, optical isomers, stereoisomers, diastereoisomers, tautomers, addition salts, biohydrolyzable amides and esters.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/031,833 | 1996-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU99113429A true RU99113429A (en) | 2001-04-10 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU99113446A (en) | GUANIDILE HETEROCYCLIC COMPOUNDS APPLIED AS AN ALPHA-2 AGONISTS ADDRENERCEEPTORS | |
LU90956I2 (en) | Metvix active ingredient methylaminolevulinic in the form of a salt preferably methylaminolevulinic hydrochloride | |
EA200200619A1 (en) | NEPEPTIDILE INHIBITORS OF VLA-4-DEPENDENT CELL ASSOCIATION USED IN THE TREATMENT OF INFLAMMATORY, AUTOIMUM AND RESPIRATORY DISEASES | |
KR950031074A (en) | Non-peptide Tachykinin Receptor Antagonists | |
RU98122210A (en) | DERIVATIVES ANDROSTENA | |
CY1112861T1 (en) | USE OF ACUTE PRODUCERS (-) (3-TRIALOMETHYLOPHOINOXY) (4-ALOFINYL) ACID FOR SURGERY TREATMENT | |
DK0561073T3 (en) | Treatment of eye hypertension | |
RU2002121646A (en) | 1,3-disubstituted pyrrolidines as alpha-2-adrenergic antagonists | |
CA2500118A1 (en) | N-substituted hydromorphones and the use thereof | |
RU2002133869A (en) | WAYS TO REDUCE CELL PROLIFERATION BASED ON (3R, 4R) C1-8 - TETRAHYDROCANABINOL-11-ONE ACIDS (HEMP ACID) | |
HU229502B1 (en) | Use of epinastine in the treatment of allergic rithinis/conjuctivitis | |
ATE15596T1 (en) | PHARMACEUTICAL AGENT. | |
EA200400311A1 (en) | CRYSTALS OF DERIVATIVES OF HYDROXYNOREPHEDRINE | |
RU2000122435A (en) | INDOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM | |
RU2000116269A (en) | 5- (2-IMIDAZOLINYLAMINAMINO) BENZIMIDAZOLE DERIVATIVES, THEIR PRODUCTION AND APPLICATION AS ALPHA-ADRENOREPTEGIN AGONISTS WITH IMPROVED METABOLIC STABILITY | |
KR960705809A (en) | Prodrugs of an inhibitor of HIV protease | |
RU2002103862A (en) | NEW AMINOBENZOPHENONES | |
RU2004111357A (en) | COMBINED AGENTS FOR TREATMENT OF GLAUCOMA | |
KR100192745B1 (en) | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases | |
RU2000106042A (en) | METHOD FOR INCREASING THE BIOLOGICAL ACCESSIBILITY OF FEXOPHENADINE AND ITS DERIVATIVES | |
CA2438509A1 (en) | Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria | |
RU99113429A (en) | GUANIDINYLAMINOHETEROCYCLIC COMPOUNDS, AS AN AGONISTS OF ALPHA-2 ADRENOCEPTORS | |
RU97107018A (en) | QUINOXALINE DERIVATIVES USED IN THERAPY | |
RU98113956A (en) | MEANS FOR PREVENTION AND TREATMENT OF DIABETIC COMPLICATIONS | |
RU2003104017A (en) | THROMBIN INHIBITORS CONTAINING AMINO-ISOCHINOLINE GROUP |